Skip to main content
. 2020 Aug 18;9(8):2674. doi: 10.3390/jcm9082674

Table 2.

Characteristics of the analyzed cohort of patients with esophageal carcinoma.

n (%)
All Sex 77 (100)
male 64 (83.1)
female 13 (16.9)
Tumor site
Squamous cell carcinoma 37 (48.1)
adenocarcinoma 39 (50.6)
Neuroendocrine tumor 1 (1.3)
Neo-adjuvant treatment
yes 32 (41.6)
no 45 (58.4)
Adjuvant treatment
yes 2 (2.5)
no 53 (68.8)
unknown 22 (28.6)